Skip to main content
Signal8

ARROWHEAD PHARMACEUTICALS, INC. (ARWR)

Arrowhead Pharmaceuticals, Inc., founded in 1989 and based in Pasadena, California, is a biopharmaceutical company dedicated to discovering and advancing innovative treatments for complex and challenging-to-treat diseases within the United States. The company's extensive therapeutic pipeline primarily leverages RNA interference (RNAi) technology. Among its advanced clinical programs are: ARO-AAT, a Phase II therapeutic targeting liver diseases associated with alpha-1 antitrypsin deficiency; ARO-APOC3, which is undergoing both Phase 2b and Phase 3 clinical evaluations for hypertriglyceridemia; ARO-ANG3, currently in Phase 2b development to reduce the production of angiopoietin-like protein 3; and ARO-HIF2, a Phase 1b candidate designed to treat clear cell renal cell carcinoma. Arrowhead also has several compounds in earlier clinical development, including ARO-HSD in Phase 1/2a for other liver diseases, ARO-ENaC in Phase 1/2a, aimed at decreasing the epithelial sodium channel alpha subunit in lung airways, and ARO-C3, also in Phase 1/2a, for complement-mediated diseases. Further expanding its diverse portfolio, the company is actively developing ARO-Lung2 for chronic obstructive pulmonary disorder (COPD), ARO-DUX4 for facioscapulohumeral muscular dystrophy, ARO-XDH for uncontrolled gout, and ARO-COV for COVID-19 and other pulmonary-borne pathogens. Beyond its core internal programs, Arrowhead is involved in the progression of JNJ-3989, a subcutaneously administered RNAi therapeutic for chronic hepatitis B virus infection; Olpasiran, intended to reduce apolipoprotein A production; and ARO-AMG1, which targets genetically validated cardiovascular pathways. Strategic collaborations are integral to Arrowhead's development efforts. The company holds a licensing and research agreement with Janssen Pharmaceuticals, Inc. for the co-development of ARO-JNJ1, ARO-JNJ2, and ARO-JNJ3, all RNAi therapeutics focused on liver-expressed targets. Additionally, Arrowhead has a licensing and research partnership with Takeda Pharmaceuticals U.S.A., Inc. to develop an RNAi therapeutic candidate specifically for liver disease.

Sector: Pharmaceutical Preparations

Industry: Biotechnology

Arrowhead Pharmaceuticals, Inc. logo

Arrowhead Pharmaceuticals, Inc.

NASDAQ:ARWRHealthcare
-0.98%$59.90
AH$59.75-0.25%vs close
Mkt Cap$8.46B
Float135.7M
O/S141.25M
Vol
$ Vol
RVOL
Inst Own84.4%
SI8.1%
Earnings
Dilution
Financials Summary
Revenue$829.45M
Net Income-$1.63M
Total Assets$1.39B
Free Cash Flow$156.89M
Debt & Equity
Debt 44%
Equity 56%
Total Debt$366.28M
Total Equity$466.05M
Shares Outstanding
Short Interest
Split History1 split · 1 reverse
  1. 1:10Reverse split
    Nov 17, 201110 shares → 1
Balance Sheet Details
Assets$1.39B
Liabilities$881.88M
Accounts Receivable$6.82M
Accounts Payable$17.67M
Inventory$0
PP&E (Net)$426.41M
Goodwill$0
Intangible Assets$6.86M
Income Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999FY 1998FY 1997
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-09-302024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-09-302005-09-302004-09-302003-09-302002-09-302001-09-302000-09-301999-09-301998-09-301997-09-30
Revenue$829.45M$3.55M$240.74M$243.23M$138.29M$87.99M$168.8M$16.14M$31.41M$158K$382K$175K$290K$147K$296K$620K$3.76M$1.3M$1.21M$595K$591K$196K$0$2K$9K$25K$37K$60K$77K
YoY Growth23258.2%-98.5%-1.0%75.9%57.2%-47.9%945.7%-48.6%19736.5%-58.6%118.3%-39.7%97.6%-50.4%-52.2%-83.5%188.4%7.9%102.9%0.8%200.9%---75.7%-62.6%-32.8%-38.7%-21.2%-
Cost of Revenue$0$18.59M$12.49M$10.42M$0$0$0$0$0$0$0$3.81M$3.17M$1.75M$268K$4.95M$9.03M$14.85M$11.78M$7.36M$644K$75K$0$87$6K$2K$3K$7K$37K
Gross Profit$829.45M-$15.04M$228.24M$232.81M$138.29M$0$0$0$0$0$0-$3.63M-$2.88M-$1.6M$28K-$4.33M-$5.26M-$13.55M-$10.57M-$6.76M-$53K$122K$0$2K$3K$23K$34K$54K$40K
Gross Margin100.0%-423.7%94.8%95.7%100.0%-------2076.2%-993.2%-1090.8%9.5%-698.7%-139.9%-1039.8%-874.8%-1135.7%-9.0%61.9%-96.2%32.4%91.6%92.3%88.9%51.7%
Research and Development$607.16M$489.22M$342.31M$288.5M$206.34M$123.54M$76.63M$48.3M$46.25M$41.45M$47.27M$23.14M$8.71M$5.39M$3.28M$857K$6.21M$8.31M$10.94M$8.58M$3.79M$793K$3K$0$0$0$0$0$0
Selling, General, and Administrative$121.92M$96.82M$90.93M$124.43M$80.98M$52.28M$26.54M$19.08M$17.46M$23.59M$34.72M$24.33M$11.69M$14.1M$6.58M$3.1M$5.97M$9.87M$6.85M$5.14M$5.52M$2.1M$91K$144K$109K$132K$90K$78K$90K
Other$2.03M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$514K$0$0$0$0$0$0$0$1.27M$0$0$0$0$108K
Total Operating Expenses$731.1M$586.04M$433.24M$411.32M$287.32M$175.21M$103.17M$67.38M$63.71M$82.45M$81.99M$47.47M$20.4M$19.49M$9.86M$4.47M$12.18M$18.18M$17.78M$13.72M$9.31M$2.89M$94K$1.42M$109K$132K$90K$78K$198K
Operating Income (EBIT)$98.35M-$601.08M-$205M-$178.51M-$149.04M-$93.16M$61.19M-$55.94M-$37M-$81.74M-$95.97M-$53.28M-$24.59M-$21.09M-$9.83M-$8.8M-$19.56M-$35M-$37.95M-$20.48M-$9.59M-$2.69M-$94K-$1.42M-$106K-$109K-$56K-$24K-$159K
Operating Margin11.9%-16927.1%-85.2%-73.4%-107.8%-105.9%36.3%-346.5%-117.8%-51627.1%-25124.1%-30443.6%-8471.3%-14358.6%-3319.5%-1419.5%-520.5%-2685.9%-3141.4%-3439.9%-1624.0%-1370.7%--62498.4%-1141.2%-439.1%-151.9%-40.2%-207.1%
Interest Expense$89.36M$32.35M$18.33M$0$0$0$0$0$0$0$0$0$98K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Interest Income$37.29M$22.72M$15.3M$5.03M$6.12M$9.19M$6.96M$1.05M$415K$266K$729K$645K$0$36K$87K$0-$5K$736.34M$0$0$151K$33K$0$0$0$0$0$0$0
Other Income (Expense)-$46.81M-$11.38M-$1.49M$5.8M$8.19M$8.61M$6.96M$1.49M$2.62M$22K$4.04M-$5.44M-$7.11M-$1.02M$1.05M$1.47M$19.56M$35M$37.95M$20.48M$9.59M$195K$0$1.17M-$80K-$28K-$312K-$141K$159K
Income Before Tax (EBT)$51.53M-$612.46M-$206.49M-$172.71M-$140.85M-$84.55M$68.15M-$54.45M-$34.38M-$81.72M-$91.94M-$58.72M-$31.7M-$22.11M-$8.79M$0$0$0$0$0$0-$2.5M-$94K-$246K-$186K-$138K-$368K-$165K$0
Income Tax Expense$21.42M-$2.77M$2.78M$3.79M$2K$2K$174K$2K$2K$2K$2K$5K$0$0$0$0$0$0$0$0$0$800$800$0$0$0$0$0$0
Net Income-$1.63M-$599.49M-$205.28M-$176.06M-$140.85M-$84.55M$67.97M-$54.45M-$34.38M-$81.72M-$91.94M-$58.63M-$31.14M-$21.13M-$3.13M-$5.77M-$19.31M-$27.09M-$29.93M-$19M-$6.85M-$2.53M-$95K-$246K-$186K-$138K$593K-$165K-$855K
Net Income Margin-0.2%-16882.4%-85.3%-72.4%-101.9%-96.1%40.3%-337.3%-109.5%-51614.6%-24068.3%-33503.0%-10729.2%-14383.6%-1056.6%-931.2%-513.8%-2078.7%-2477.7%-3190.4%-1160.5%-1287.9%--10865.3%-1995.5%-552.9%1602.8%-273.3%-1115.7%
Supplementary Data
EPS-0.01-5.00-1.92-1.67-1.36-0.840.72-0.65-0.47-1.34-1.60-1.25-1.30-1.90-0.44-0.90-4.27-6.91-8.35-5.95-2.61-1.88-11.78-32.47-25.97-19.4859.30-5.16-85.45
Diluted EPS-0.01-5.00-1.92-1.67-1.36-0.840.69-0.65-0.47-1.34-1.60-1.25-1.30-1.90-0.44-0.90-4.27-6.91-8.35-5.95-2.61-1.88-11.78-32.47-25.97-19.4859.30-5.16-85.45
Weighted Average OS133.76M119.78M106.75M105.43M103.75M100.72M93.86M83.64M73.15M60.99M57.36M46.90M23.96M11.12M7.18M6.43M4.52M3.92M3.59M3.20M2.54M1.33M8,0857,5837,1547,06110,00010,00010,000
EBITDA$164.82M-$561.51M-$175.67M-$162.29M-$132.58M-$87.22M$65.63M-$51.24M-$32.31M-$76.43M-$93.64M-$49.76M-$21.53M-$19.34M-$9.56M$655K-$18.57M-$33.87M-$36.95M-$19.6M-$8.95M-$2.62M-$94K-$1.41M-$103K-$102K-$48K-$15K-$55K
EBITDA Margin19.9%-15812.8%-73.0%-66.7%-95.9%-99.1%38.9%-317.4%-102.9%-48272.9%-24512.5%-28433.3%-7417.3%-13167.8%-3229.0%105.6%-494.0%-2598.9%-3058.3%-3291.0%-1515.0%-1332.7%--62097.8%-1103.3%-408.4%-130.0%-25.0%-71.6%
Balance Sheet
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999FY 1998FY 1997
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-09-302024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-09-302005-09-302004-09-302003-09-302002-09-302001-09-302000-09-301999-09-301998-09-301997-09-30
Assets
Current Assets
Cash and Cash Equivalents$226.55M$102.69M$110.89M$108M$184.43M$143.58M$221.8M$30.13M$24.84M$85.37M$81.21M$132.51M$19.11M$3.38M$7.51M$6.85M$2.02M$10.09M$24.12M$28.02M$22.47M$8.55M$1.36M$18K$271$2K$124$1K$1K
Short-Term Investments$692.82M$578.28M$292.74M$268.39M$183.35M$171.91M$36.9M$46.4M$40.77M$0$17.54M$21.65M$9.03M$107K$635K$0$0$0$0$0$77K$488K$0$0$0$0$0$0$0
Cash and Short-Term Investments$919.37M$680.96M$403.63M$376.4M$367.79M$315.49M$258.7M$76.53M$65.61M$85.37M$98.75M$154.16M$28.14M$3.48M$8.14M$6.85M$2.02M$10.09M$24.12M$28.02M$22.54M$9.04M$1.36M$18K$271$2K$124$1K$1K
Accounts Receivable$6.82M$0$0$1.41M$10.26M$846K$661K$327K$68K$75K$0$0$84K$2.47M$1.61M$931K$147K$87K$276K$74K$33K$52K$0$0$640$1K$11K$3K$10K
Inventory$0$0$0-$21.61M$4.36M$4.25M$3.32M$1.27M$867K$1.29M$0$0$0$0$0$239K$0$0$0$0$0$0$0$13K$6K$12K$14K$22K$22K
Other Current Assets$13.52M$4.97M$7.08M$41.82M-$2.17M-$2.47M-$755K$640K$1.36M$3.77M$824K$49K$92K$0$0$0$0$0$0$0$0$0$0$0$38K$0$0$7K$0
Total Current Assets$950.64M$695.47M$419.52M$405.3M$384.6M$322.37M$265.25M$78.77M$67.9M$90.5M$102.87M$154.8M$28.84M$6.57M$9.86M$8.13M$2.48M$10.56M$25.31M$28.78M$22.81M$9.5M$1.51M$32K$46K$16K$26K$30K$34K
Long-Term Assets
Property, Plant & Equipment Net$426.41M$431.29M$335.56M$168.59M$66.02M$47.02M$23.21M$13.94M$15.51M$15.39M$4.53M$3.87M$3.51M$4.9M$25K$141K$527K$1.25M$1.44M$1.27M$1.08M$882K$2K$31K$446$49K$56K$49K$64K
Goodwill$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$963K$1.76M$399K$0$0$0$0$0$0$0
Intangible Assets$6.86M$8.56M$10.26M$11.96M$13.66M$15.36M$17.06M$18.76M$20.46M$22.16M$24.82M$1.01M$3.24M$4.78M$1.73M$2.05M$2.36M$2.75M$2.94M$3.35M$3.28M$1.06M$0$0$0$0$0$0$0
Long-Term Investments$0$0$0$105.87M$245.59M$137.49M$44.18M$0$0$0$0$23.09M$1.7M$0$1.84M$2M$2.22M$0$0$0$0$0$0$0$0$0$0$0$0
Deferred Tax Assets$0$0$0$0$0$0$0$0$0$0$0$0-$1.7M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Assets$1.39M$4.48M$210K$218K$272K$265K$144K$142K$142K$122K$46K$41K$1.73M$280K$2.43M$35K$110K$2.7M$170K$161K$110K$75K$0$0$0$0$0$6K$9K
Total Long-Term Assets$434.66M$444.33M$346.03M$286.64M$325.55M$200.13M$84.6M$32.84M$36.12M$37.67M$29.4M$28.02M$8.49M$9.96M$6.03M$4.22M$5.22M$6.69M$4.55M$5.75M$6.23M$2.42M$2K$31K$446$49K$56K$55K$74K
Other Assets$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Total Assets$1.39B$1.14B$765.55M$691.94M$710.15M$522.5M$349.85M$111.61M$104.02M$128.18M$132.27M$182.82M$37.33M$16.53M$15.89M$12.35M$7.7M$17.26M$29.85M$34.53M$29.04M$11.92M$1.52M$64K$46K$65K$82K$85K$108K
Liabilities
Current Liabilities
Accounts Payable$17.67M$11.39M$35.87M$2.87M$9.46M$6.83M$7.65M$2.81M$4.08M$12.23M$5.03M$2.58M$1.2M$878K$577K$682K$1.01M$1.34M$1.35M$847K$472K$541K$93K$259K$180K$161K$169K$1.4M$1.42M
Short-Term Debt$40M$6.34M$10.56M$2.78M$2.25M$1.09M$0$224K$209K$194K$218K$264K$1.19M$215K$0$500K$727K$810K$0$0$0$0$0$606K$526K$524K$522K$1.02M$1.02M
Current Income Tax Payable$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Current Unearned Revenue$2.4M$0$866K$74.1M$111.06M$19.29M$77.77M$600$5.71M$3.01M$103K$103K$103K$38K$0$0$0$0$0$0$0$0$0$0$612K$0$0$207K$0
Other Current Liabilities$80.43M$63.45M$40.2M$46.86M$14M$5.41M$6.7M$5.4M$5.31M$6.24M$6.72M$5.63M$5.32M$3.07M$1.81M$2.88M$444K$1.09M$1.14M$1.84M$371K$82K$3K$0$0$0$0-$171K$0
Total Current Liabilities$195.49M$103.17M$105.46M$138.85M$146.54M$40.68M$97.07M$12.36M$18.7M$25.64M$15.9M$11.85M$8.73M$5.33M$2.58M$4.28M$2.34M$3.73M$2.9M$2.92M$1.02M$690K$96K$1.59M$1.32M$1.16M$1.04M$2.67M$2.68M
Long-Term Liabilities
Long-Term Debt$214.88M$734.54M$268.33M$0$0$0$0$2.1M$2.33M$2.53M$0$0$50K$839K$607K$0$500K$0$0$0$0$0$0$28K$33K$39K$43K$45K$0
Long-Term Unearned Revenue$0$0$0$55.95M$131.5M$0$5.04M$0$0$2.5M$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Long-Term Deferred Tax Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Long-Term Liabilities$367.4M$0$0$0$0$0$3.7M$1.9M$2.13M$2.47M$6.2M$4.23M$1.76M$269K$136K$0$0$500K$500K$0$0$0$0$0$0$0$0$0$0
Total Long-Term Liabilities$686.39M$845.57M$372.93M$134.75M$154.79M$20.04M$8.74M$4M$4.45M$7.51M$6.75M$4.98M$2.87M$2.39M$742K$0$500K$1.23M$500K$0$0$0$0$28K$33K$39K$43K$45K$0
Other Liabilities$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0-$934.44M-$1.89M-$1.78M$0$0$0$0$0$0$0
Total Liabilities$881.88M$948.74M$478.39M$273.6M$301.33M$60.72M$105.81M$16.37M$23.16M$33.15M$22.65M$16.83M$11.59M$7.72M$3.32M$4.28M$2.84M$4.95M$3.4M$2.92M$1.02M$690K$96K$1.61M$1.35M$1.19M$1.08M$2.71M$2.68M
Stockholders' Equity
Preferred Stock$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$2K$2K$2K$2K$114$114
Common Stock$231K$217K$200K$198K$197K$195K$188K$181K$167K$162K$152K$147K$125K$108K$86K$72K$56K$43K$39K$34K$28K$14K$5K$5K$5K$5K$5K$3K$3K
Retained Earnings-$1.63B-$1.63B-$1.03B-$820.75M-$644.69M-$503.84M-$419.29M-$487.27M-$432.82M-$398.44M-$316.71M-$224.77M-$166.14M-$135M-$113.87M-$110.74M-$104.97M-$85.5M-$58.41M-$28.48M-$9.22M-$2.59M-$95K-$9.61M-$9.37M-$9.18M-$9.04M-$9.47M-$9.41M
Comprehensive Income & Other$6.44M$4.75M-$3.22M-$136K-$69K$18K-$392K-$22K$33K$7K-$136K-$4.19M-$3.08M-$1.57M-$340K-$1.18M-$1.03M-$1.6M-$1.68M-$1.09M-$728K-$194K$0-$82K-$11K-$69K-$62K-$92K-$77K
Other Stockholders' Equity$2.09B$1.81B$1.3B$1.22B$1.05B$965.43M$663.69M$582.88M$514.07M$493.85M$426.74M$391.16M$193.51M$145.92M$127.48M$119.72M$109.77M$97.76M$84.67M$59.11M$35.32M$12.03M$1.51M$8.06M$8.06M$8.05M$8.04M$6.83M$6.83M
Total Equity$466.05M$185.44M$271.34M$398.52M$408.82M$461.78M$244.59M$95.8M$81.42M$95.58M$110.18M$166.54M$27.5M$11.03M$13.69M$9.05M$4.86M$12.3M$26.3M$30.67M$26.13M$9.45M$1.42M-$1.55M-$1.3M-$1.13M-$996K-$2.63M-$2.58M
Minority Interest$37.36M$5.62M$15.82M$19.82M$0$0-$555K-$555K-$555K-$555K-$555K-$555K-$1.76M-$1.2M-$227K-$967K$0$0$153K$934K$1.89M$1.78M$0$0$0$0$0$0$0
Total Liabilities and Equity$1.35B$1.13B$749.73M$672.12M$710.15M$522.5M$350.4M$112.17M$104.58M$128.73M$132.82M$183.37M$39.09M$18.75M$17.02M$13.32M$7.7M$17.26M$29.7M$33.59M$27.15M$10.14M$1.52M$64K$46K$65K$82K$85K$108K
Supplementary Data
Total Debt$366.28M$851.91M$383.5M$81.58M$25.55M$21.14M$0$2.33M$2.53M$2.73M$758K$1.02M$2.3M$2.34M$607K$500K$1.23M$1.54M$0$0$0$0$0$634K$559K$563K$565K$1.34M$1.02M
Net Debt$139.74M$749.23M$272.61M-$26.43M-$158.89M-$122.44M-$221.8M-$27.81M-$22.31M-$82.64M-$80.46M-$131.49M-$16.81M-$1.04M-$6.9M-$6.35M-$794K-$8.56M-$24.12M$0-$22.47M-$8.55M-$1.36M$615K$559K$561K$565K$1.34M$1.02M
Cash Flow Statement
PeriodFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017FY 2016FY 2015FY 2014FY 2013FY 2012FY 2011FY 2010FY 2009FY 2008FY 2007FY 2006FY 2005FY 2004FY 2003FY 2002FY 2001FY 2000FY 1999FY 1998FY 1997
CurrencyUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Period Ending2025-09-302024-09-302023-09-302022-09-302021-09-302020-09-302019-09-302018-09-302017-09-302016-09-302015-09-302014-09-302013-09-302012-09-302011-09-302010-09-302009-09-302008-09-302007-09-302006-09-302005-09-302004-09-302003-09-302002-09-302001-09-302000-09-301999-09-301998-09-301997-09-30
Operating Activities
Net Income$30.11M-$609.69M-$209.28M-$176.49M-$140.85M-$84.55M$67.97M-$54.45M-$34.38M-$81.72M-$91.94M-$58.63M-$31.14M-$21.13M-$5.29M-$4.31M-$19.14M-$27.09M-$29.93M-$19M-$6.85M-$2.53M-$95K-$246K-$186K-$138K$593K-$165K-$855K
Depreciation & Amortization$23.93M$18.59M$12.49M$10.42M$8.27M$5.94M$4.44M$4.7M$4.69M$3.26M$2.34M$1.35M$1.75M$1.75M$268K$655K$995K$1.13M$1M$887K$644K$75K$90$9K$4K$8K$8K$9K$104K
Deferred Income Tax$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Stock-Based Compensation$63.37M$73.97M$78.13M$120.89M$76.67M$43.38M$12.39M$8.45M$7.89M$11.6M$10.23M$5.7M$1.54M$1.24M$1.38M$1.42M$2.68M$0$0$0$0$0$0$0$0$0$0$0$0
Changes in Working Capital:
  Accounts Receivable-$56.97M$0$1.41M$8.85M-$9.41M-$184K-$334K-$260K$7K-$75K$0$75K-$65K-$775K-$736K-$872K-$61K$189K-$202K-$41K$18K-$52K$0$568$640$9K$3K$6K$10K
  Inventory$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0-$7K$6K$2K$2K-$1K$25K
  Accounts Payable$6.29M-$5.54M$33M-$6.59M$2.63M-$821K$4.84M-$1.27M-$3.51M$2.55M$2.5M$1.41M$322K$292K$157K-$203K-$329K$0$0$0$0$0$0$0$0$0$0$0$0
  Other Working Capital$32.45M$30.63M-$85.95M-$100.55M$235.44M-$60.07M$82.65M-$4.35M$2.3M$3.24M$910K$3.52M-$117K$700K$586K$174K-$435K-$422K$242K$1.4M$426K$93K-$62K$189K$145K$38K$59K$149K$53K
Total Working Capital Change-$18.23M$25.09M-$51.55M-$98.29M$228.66M-$61.08M$87.16M-$5.88M-$1.21M$5.72M$3.41M$5M$140K$216K$7K-$902K-$825K-$233K$41K$1.36M$445K$41K-$62K$183K$152K$49K$64K$153K$88K
Other Non-Cash Items$80.38M$29.19M$16.31M$7.34M-$1.44M$505K$1.07M-$49K-$934K-$3.28M$10.26M$11.17M$8.68M$2.58M-$1.75M-$4.56M$1.02M-$1.4M$5.02M$1.96M-$3.33M$99K$0-$52K-$52K$816-$701K$2K$667K
Net Cash from Operating$179.55M-$462.85M-$153.89M-$136.13M$171.31M-$95.8M$173.03M-$47.22M-$23.94M-$64.43M-$65.71M-$35.42M-$19.03M-$15.34M-$5.39M-$7.7M-$15.28M-$27.58M-$23.87M-$14.79M-$9.1M-$2.31M-$158K-$106K-$82K-$80K-$35K$56$5K
Investing Activities
Capital Expenditures-$22.67M-$141.47M-$176.74M-$52.78M-$23.57M-$11.95M-$12M-$1.42M-$7.92M-$3.86M-$1.97M-$1.72M-$297K-$480K-$10K-$5K-$40K-$684K-$756K-$935K-$673K-$665K-$2K-$2K$0-$742$0$0$0
Acquisitions$0$0$0$0$0$0$0$0$0$0-$10M$0$0$121K-$1.7M$0$0$109K$5.14M$0-$8M$306K$0$0$0$0$0$0$0
Purchases of Investments-$796.26M-$720.95M-$246.14M-$223.39M-$240.7M-$278.96M-$90.27M-$52.08M-$44.97M$0$0-$46.37M-$10.73M$0$0$0$0$0$0-$18.58M$0$0$0$0$0$0$0$0$0
Sales of Investments$689.63M$442.34M$326.72M$270.75M$122.59M$50.14M$54.52M$46.07M$4.25M$17.31M$26.09M$11.59M$1.42M$509K$1.53M$0$700K$0$0$18.97M$490K$0$0$0$0$0$0$0$0
Other Investing Activities$0$0$0$0$0$0$0$0$0$0$500$10K$90K$290K$0$493K$79K-$2M$0$0$10.45M$0$0$0$0$0$0$0$0
Net Cash from Investing-$129.29M-$420.07M-$96.16M-$5.42M-$141.68M-$240.78M-$47.75M-$7.43M-$48.64M$13.45M$14.12M-$36.48M-$9.52M$441K-$175K$488K$739K-$2.57M$4.38M-$542K$2.27M-$360K-$2K-$2K$0-$742$0$0$0
Financing Activities
Debt Repaid$201.63M-$392M----$2.42M$209K$198K$218K$214K$225K$215K$197K---$2.52M---------$1K$203$4K
Common Stock Issuance$270.37M$431.65M$3.05M$5.19M$0$250.48M$60.52M$56.59M$12.42M$52.23M$0$172.64M$42.45M$10.89M$6.23M$12.17M$2.76M$16.27M$15.59M$20.89M$20.74M$9.87M$5K$0$0$0$0$0$0
Common Stock Repurchases$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Dividends Paid$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Other Financing Activities-$5M$46.87M$250M$60M$11.3M$7.47M$8.28M$3.58M-$166K$3.12M$505K$12.88M$2.06M$74K$0-$127K$2M$0$0$0$0$0$1.51M$0$0$85K$35K$0$0
Net Cash from Financing$74.01M$870.52M$253.05M$65.19M$11.3M$257.95M$66.38M$59.95M$12.06M$55.13M$291K$185.29M$44.29M$10.77M$6.23M$12.04M$6.47M$16.13M$15.59M$20.89M$20.74M$9.87M$1.51M$126K$80K$83K$34K-$203-$4K
Forex Effect-$401K$4.2M-$122K-$67K-$88K$410K$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0$0
Net Change in Cash$123.86M-$8.21M$2.89M-$76.43M$40.85M-$78.22M$191.67M$5.29M-$60.53M$4.15M-$51.3M$113.4M$15.74M-$4.13M$660K$4.83M-$8.07M-$14.03M-$3.9M$5.55M$13.91M$7.2M$1.36M$18K-$2K$2K-$894-$147$131
Supplementary Data
Operating Cash Flow$179.55M-$462.85M-$153.89M-$136.13M$171.31M-$95.8M$173.03M-$47.22M-$23.94M-$64.43M-$65.71M-$35.42M-$19.03M-$15.34M-$5.39M-$7.7M-$15.28M-$27.58M-$23.87M-$14.79M-$9.1M-$2.31M-$158K-$106K-$82K-$80K-$35K$56$5K
Capital Expenditure-$22.67M-$141.47M-$176.74M-$52.78M-$23.57M-$11.95M-$12M-$1.42M-$7.92M-$3.86M-$1.97M-$1.72M-$297K-$480K-$10K-$5K-$40K-$684K-$756K-$935K-$673K-$665K-$2K-$2K$0-$742$0$0$0
Free Cash Flow$156.89M-$604.32M-$330.63M-$188.91M$147.75M-$107.75M$161.03M-$48.64M-$31.86M-$68.29M-$67.68M-$37.13M-$19.33M-$15.82M-$5.4M-$7.7M-$15.32M-$28.27M-$24.62M-$15.73M-$9.77M-$2.98M-$160K-$108K-$82K-$81K-$35K$56$5K
Cash at Beginning$102.69M$110.89M$108M$184.43M$143.58M$221.8M$30.13M$24.84M$85.37M$81.21M$132.51M$19.11M$3.38M$7.51M$6.85M$2.02M$10.09M$24.12M$28.02M$22.47M$8.55M$1.36M$0$271$2K$124$1K$1K$1K
Cash at End$226.55M$102.69M$110.89M$108M$184.43M$143.58M$221.8M$30.13M$24.84M$85.37M$81.21M$132.51M$19.11M$3.38M$7.51M$6.85M$2.02M$10.09M$24.12M$28.02M$22.47M$8.55M$1.36M$18K$271$2K$124$1K$1K